Literature DB >> 1486480

Blockade of NMDA receptor-mediated mobilization of intracellular Ca2+ prevents neurotoxicity.

S Z Lei1, D Zhang, A E Abele, S A Lipton.   

Abstract

NMDA receptor activation leads to elevated Ca2+ in cultured rat cortical and retinal ganglion cell neurons. If excessive, this Ca2+ response is associated with delayed neurotoxicity. We used dantrolene and ionomycin to test if the Ca2+ response to NMDA was due to mobilization of intracellular Ca2+ stores rather than merely to Ca2+ influx. In the presence of EGTA, ionomycin resulted in release and subsequent depletion of intracellular Ca2+ stores. Henceforth, despite normal extracellular Ca2+, NMDA elicited only about half of its former Ca2+ response. Similarly, when dantrolene was used to block Ca2+ release from intracellular stores, we observed > 50% smaller NMDA-evoked Ca2+ responses. These results quite surprisingly indicate that at least half the Ca2+ response to NMDA is due to release of intracellular Ca2+, a process triggered by influx of extracellular Ca2+. Dantrolene also protected neurons from NMDA receptor-mediated neurotoxicity. Release of intracellular Ca2+ may therefore be a necessary step in the cascade leading to neuronal damage induced by excessive NMDA receptor stimulation and may be amenable to pharmacological intervention.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486480     DOI: 10.1016/0006-8993(92)90183-a

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Ca2+ entry pathways in mouse spinal motor neurons in culture following in vitro exposure to methylmercury.

Authors:  Gunasekaran Ramanathan; William D Atchison
Journal:  Neurotoxicology       Date:  2011-08-02       Impact factor: 4.294

2.  Electrophysiological mechanisms of delayed excitotoxicity: positive feedback loop between NMDA receptor current and depolarization-mediated glutamate release.

Authors:  C M Norris; E M Blalock; O Thibault; L D Brewer; G V Clodfelter; N M Porter; P W Landfield
Journal:  J Neurophysiol       Date:  2006-08-16       Impact factor: 2.714

3.  Hypothermia reduces calcium entry via the N-methyl-D-aspartate and ryanodine receptors in cultured hippocampal neurons.

Authors:  Kristin F Phillips; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2012-10-17       Impact factor: 4.432

4.  NMDA receptor-mediated calcium influx in cerebral cortical synaptosomes of the hypoxic guinea pig fetus.

Authors:  S A Zanelli; Y Numagami; J E McGowan; O P Mishra; M Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

Review 5.  Mechanisms of L-cysteine neurotoxicity.

Authors:  R Janáky; V Varga; A Hermann; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

6.  Effect of dantrolene on KCl- or NMDA-induced intracellular Ca2+ changes and spontaneous Ca2+ oscillation in cultured rat frontal cortical neurons.

Authors:  T Hayashi; A Kagaya; M Takebayashi; T Oyamada; M Inagaki; Y Tawara; N Yokota; J Horiguchi; T P Su; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Optical recordings of the effects of cholinergic ligands on neurons in the ganglion cell layer of mammalian retina.

Authors:  W H Baldridge
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

8.  Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures.

Authors:  V L Dawson; T M Dawson; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

Authors:  B Jiang; S Liang; G Liang; H Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-10       Impact factor: 3.507

10.  Calcium antagonists in N-methyl d-aspartate-induced retinal injury.

Authors:  Murat Kaya; Murat Tunç; Talha Ozdemir; Irfan Altuntaş
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.